Log In
Print
BCIQ
Print
Print this Print this
 

ABT-560

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionNeuronal nicotinic receptor modulator
Molecular Target Nicotinic receptor
Mechanism of ActionNicotinic receptor modulator
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCognitive dysfunction
Indication DetailsTreat cognitive dysfunction
Regulatory Designation

Partner

NeuroSearch A/S


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today